“At Imperial we are attacking antimicrobial resistance from all angles,” Alice Gast, president of Imperial College London, said at the collaborative’s official launch. “By bringing together leaders in microbiology, engineering, chemistry, clinical research, epidemiology, health economics, and more, we take a holistic approach to tackling this great threat to humanity.”
Here are four things to know about the collaborative.
• The initiative will include members from various Imperial College faculties and the Imperial College Healthcare National Health Society Trust, as well as industry and third-party collaborators.
• The group will conduct interdisciplinary research into drug-resistant infections and prevention strategies and therapies, taking a global perspective on protecting populations from infection risk.
• At the launch event, discussions were held on research topics that fall under the ARC’s domain, ranging from molecular biology to the use of healthcare data to create policies related to antimicrobial resistance.
• As part of the launch, six recipients from the Imperial College London School of Public Health’s department of medicine and life sciences were awarded ARC Early Career Research Fellowships, which provide one year of funding for antimicrobial resistance research.
More articles on infection control:
Spring City, Pa., residents monitored after Legionella found in water treatment system
C. diff pesticide found ineffective, EPA takes action
Pennsylvania hospitals reduce HAIs by 7%
